Search clinical trials for: Buprenorphine/naloxone

Total 691 results

Duke University
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 (Pharm-OUD-Care)

Opioid Use Disorder

United States
Montefiore Medical Center

Recruiting

Low-dose Buprenorphine Initiation for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

Opiate Dependence

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
CBT4CBT, LLC

Completed

CBT4CBT for Office Based Buprenorphine

Opioid-use Disorder

United States
Indivior Inc.

Completed

Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") (RIME)

Opioid Dependency

France
Wayne State University

Completed

Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence (BOS)

Heroin Dependence | Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone Combination Study - 10

Opioid-Related Disorders | Heroin Dependence

United States
Orexo AB
Worldwide Clinical Trials

Completed

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Opioid-Related Disorders | Opiate Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Substance-Related Disorders | Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

Opioid-Related Disorders

United States
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
Bicycle Health

Enrolling by invitation

Novel Induction to Buprenorphine/Naloxone

Opioid Use Disorder | Opioid Dependence | Opioid Use | Opioid Abuse | Opioid Misuse

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Abuse Potential of Buprenorphine/Naloxone

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
Maimonides Medical Center

Terminated

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Opioid Use Disorder

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
Massachusetts General Hospital

Not yet recruiting

Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients

Post-operative Pain

United States
University of Pennsylvania
Public Health Management Corporation; Philadelphia Department of Public Health and other collaborators

Completed

Rapid Initiation of Drug Treatment Engagement (RIDE)

Overdose | Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Substance-Related Disorders | Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
New York State Psychiatric Institute
Alkermes, Inc.

Terminated

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Heroin Dependence

United States
NanoSHIFT LLC

Completed

A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

Healthy

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA)

Terminated

Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users

HIV Infections | Opioid-Related Disorders

China, Thailand
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
University of British Columbia

Recruiting

Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

Opioid-use Disorder

Canada
Milton S. Hershey Medical Center

Recruiting

Buprenorphine Induction for Fentanyl Dependent Opioid Users

Opioid Dependence Fentanyl

United States
Indivior Inc.

Completed

Safety and Tolerability of Buprenorphine/Naloxone Film Strips

Opioid-Related Disorders

United States
State University of New York at Buffalo

Terminated

Buprenorphine as a Treatment in Opiate Dependent Pain Patients

Opiate Addiction | Refractory Pain

United States
Nassima Ait-Daoud Tiouririne

Unknown

Measures to Improve Outcomes After an Opioid Overdose

Opioid Overdose

United States
Vertex Pharmaceuticals Incorporated
Tibotec BVBA

Completed

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Hepatitis C | Opioid-Related Disorders

United States
Indivior Inc.

Completed

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder

United States
Massachusetts General Hospital

Not yet recruiting

A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Opioid-use Disorder | Opioid Use Disorder, Mild
Indivior Inc.

Completed

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)

Drug Abuse | Opiate Dependence | Opiate-related Disorders
Indivior Inc.

Completed

A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)

Opiate Dependence | Drug Dependence
NYU Langone Health
Emergency Medicine Foundation

Completed

Buprenorphine Loading in the Emergency Department

Opioid-use Disorder

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Baltimore City Health Department

Enrolling by invitation

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine (OUTLAST-B)

Opioid-use Disorder

United States
University of Vermont

Unknown

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Opioid-use Disorder

United States
Indivior Inc.

Completed

Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone

Opioid-related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Recruiting

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder (COMBO)

Opioid-use Disorder

United States
University of California, Davis
Yale University; University of Utah

Not yet recruiting

Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder (PEDsTREATOUD)

Opioid-use Disorder
MedicaSafe, Inc.
Friends Research Institute, Inc.

Unknown

Improving Office Based Treatment of Opioid Use Disorder With Technology

Opioid-use Disorder

United States
Massachusetts General Hospital

Unknown

Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use

Surgery | Pain, Acute | Opioid-use Disorder
National Institute on Drug Abuse (NIDA)
Organization to Achieve Solutions in Substance Abuse (OASIS)

Completed

Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1

Hepatitis C | Heroin Dependence

United States

Search clinical trials for: Buprenorphine/naloxone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations